Radiolabelling DOTA-HYNIC-panPSMA with actinium-225 for in vivo studies

被引：0
|
作者：
Roetman, J. [1 ]
Attia, K. [1 ]
Hallund, M. W. [2 ]
Jorgensen, K. R. [2 ]
机构：
[1] Telix Pharmaceut, Melbourne, Vic, Australia
[2] Minerva Imaging, Olstykke, Denmark
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0985
引用
收藏
页码：S825 / S826
页数：2
相关论文
共 13 条
  • [1] Improved in vivo stability of actinium-225 macrocyclic complexes
    Deal, KA
    Davis, IA
    Mirzadeh, S
    Kennel, SJ
    Brechbiel, MW
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 2988 - 2992
  • [2] Targeted actinium-225 in vivo generators for therapy of ovarian cancer
    Borchardt, PE
    Yuan, RR
    Miederer, M
    McDevitt, MR
    Scheinberg, DA
    CANCER RESEARCH, 2003, 63 (16) : 5084 - 5090
  • [3] Production and purification of radium-225/actinium-225 at TRIUMF's ISOL facility and subsequent radiolabeling studies with alpha-emitting daughter actinium-225
    Ramogida, Caterina F.
    Robertson, Andrew K. H.
    Kunz, Peter
    Bratanovic, Ivica
    Spreckelmeyer, Sarah
    Lassen, Jens
    Orvig, Chris
    Schaffer, Paul
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S25 - S25
  • [4] Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies
    Jurcic, Joseph G.
    CURRENT RADIOPHARMACEUTICALS, 2018, 11 (03) : 192 - 199
  • [5] Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors
    Handula, Maryana
    de Blois, Erik
    Denkova, Antonia
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S191 - S191
  • [6] Production of actinium-225 from a (n,p) reaction: Feasibility and pre-design studies
    Abolaban, Fouad A.
    Banoqitah, Essam M.
    Taha, Eslam M.
    Alhawsawi, Abdulsalam M.
    Djouider, Fathi A.
    Nisbet, Andrew
    NUKLEONIKA, 2021, 66 (02) : 61 - 67
  • [7] Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of 225Ac-crown-αMSH Peptide
    Yang, Hua
    Zhang, Chengcheng
    Yuan, Zheliang
    Rodriguez-Rodriguez, Cristina
    Robertson, Andrew
    Radchenko, Valery
    Perron, Randy
    Gendron, Denise
    Causey, Patrick
    Gao, Feng
    Benard, Francois
    Schaffer, Paul
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (50) : 11435 - 11440
  • [8] In vivo Evaluation of Free and Chelated Accelerator-produced Actinium-225 - Radiation Dosimetry and Toxicity Results
    Jiang, Zewei
    Revskaya, Ekaterina
    Fisher, Darrell R.
    Dadachova, Ekaterina
    CURRENT RADIOPHARMACEUTICALS, 2018, 11 (03) : 215 - 222
  • [9] Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
    Qin, Yun
    Imobersteg, Stefan
    Blanc, Alain
    Frank, Stephan
    Schibli, Roger
    Behe, Martin P.
    Grzmil, Michal
    PHARMACEUTICS, 2020, 12 (11) : 1 - 12
  • [10] Qualitative and quantitative SPECT/CT imaging of actinium-225 for targeted therapy of gliomas phantom studies.
    Tulik, M.
    Kulinski, R.
    Tabor, Z.
    Brzozowska, B.
    Laba, P.
    Bruchertseifer, F.
    Morgenstern, A.
    Krolicki, L.
    Kunikowska, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S801 - S802
12